title: Recurrent Fevers After Infliximab Therapy for Ulcerative Colitis.
authors.affiliation: Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada.
authors.forename: Christopher
authors.initials: C
authors.lastname: Ma
authors.affiliation: Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada.
authors.forename: Richard N
authors.initials: RN
authors.lastname: Fedorak
authors.affiliation: Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada.
authors.forename: Brendan P
authors.initials: BP
authors.lastname: Halloran
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D001707:Biopsy, Needle; D001853:Bone Marrow / Q000473:pathology; D001999:Bronchoscopy / Q000379:methods; D003093:Colitis, Ulcerative / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology*; D018450:Disease Progression; D017809:Fatal Outcome; D005334:Fever / Q000175:diagnosis / Q000209:etiology; D006801:Humans; D016867:Immunocompromised Host; D000069285:Infliximab / Q000009:adverse effects / Q000627:therapeutic use*; D051359:Lymphohistiocytosis, Hemophagocytic / Q000175:diagnosis* / Q000209:etiology*; D008297:Male; D013902:Radiography, Thoracic / Q000379:methods; D012008:Recurrence; D018570:Risk Assessment; D012720:Severity of Illness Index; D012812:Sigmoidoscopy / Q000379:methods
chemical_list: D000911:Antibodies, Monoclonal; D000069285:Infliximab